1. Home
  2. Labeler Index
  3. Eisai Inc.
  4. 62856-212
  5. Product Images: Leqembi

Product Images Leqembi

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Leqembi NDC 62856-212 by Eisai Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1: Reduction in Brain Amyloid Beta Plaque (Adjusted Mean Change from Baseline in Amyloid Beta PET Composite, SUVR and Centiloids) in Study 1 - lecanemab 01

Figure 1: Reduction in Brain Amyloid Beta Plaque (Adjusted Mean Change from Baseline in Amyloid Beta PET Composite, SUVR and Centiloids) in Study 1 - lecanemab 01

PRINCIPAL DISPLAY PANELLEQEMBINDC 62856-215-01(lecanemab-irmb)Injection500 mg/5 mL(100 mg/mL)Single-Dose Vial - lecanemab 02

PRINCIPAL DISPLAY PANELLEQEMBINDC 62856-215-01(lecanemab-irmb)Injection500 mg/5 mL(100 mg/mL)Single-Dose Vial - lecanemab 02

LEQEMBI" is a prescription drug for intravenous infusion only. The injection must be diluted before use, with a dosage prescribed by a doctor. The drug is available in a single-dose vial and manufactured by Eisai Inc. The unused portion should be discarded. No further information is available from the provided text.*

PRINCIPAL DISPLAY PANELLEQEMBINDC 62856-215-01(lecanemab-irmb)Injection500 mg/5 mL(100 mg/mL) - lecanemab 03

PRINCIPAL DISPLAY PANELLEQEMBINDC 62856-215-01(lecanemab-irmb)Injection500 mg/5 mL(100 mg/mL) - lecanemab 03

PRINCIPAL DISPLAY PANELLEQEMBINDC 62856-212-01(lecanemab-irmb)Injection200 mg/2 mL(100 mg/mL)Single-Dose Vial - lecanemab 04

PRINCIPAL DISPLAY PANELLEQEMBINDC 62856-212-01(lecanemab-irmb)Injection200 mg/2 mL(100 mg/mL)Single-Dose Vial - lecanemab 04

This is a description of a medication named "LEQEMBI" (lecanemab-irmb). It is an injection drug that comes in a 200 mg/2 mL single-dose vial. Unused portions must be discarded. The NDC code is 62856-212-01, and the medication is for intravenous infusion only after prior dilution. The prescribing information should be consulted for the proper dosage. It is manufactured by Eisai Inc., with US License No. 1862.*

PRINCIPAL DISPLAY PANELLEQEMBINDC 62856-212-01(lecanemab-irmb)Injection200 mg/2 mL(100 mg/mL) - lecanemab 05

PRINCIPAL DISPLAY PANELLEQEMBINDC 62856-212-01(lecanemab-irmb)Injection200 mg/2 mL(100 mg/mL) - lecanemab 05

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.